Topiramate

Prescription ·Strong evidence ·Reviewed May 2026

Topiramate is a broad-spectrum antiepileptic approved for partial-onset and primary generalized tonic-clonic seizures, Lennox-Gastaut syndrome, and migraine prophylaxis. It is also used off-label for weight management (a component of Qsymia), essential tremor, and binge eating disorder.

What it's good for
  • Broad-spectrum seizure control1,8
  • Migraine prevention8,10
  • Weight-neutral to weight-loss promoting
  • Effective as monotherapy or adjunctive therapy2,9
What to watch for
  • Cognitive dysfunction (word-finding difficulty, impaired concentration)
  • Paresthesias (tingling in extremities)
  • Weight loss and decreased appetite
  • Known hypersensitivity to topiramate1,2
  • Concurrent use with alcohol (increased CNS depression and metabolic acidosis risk)2,5

The bottom line

Evidence rating strong. Most-documented uses: broad-spectrum seizure control, migraine prevention, weight-neutral to weight-loss promoting. 10 sources indexed (2010–2023), with 3 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Exerts anticonvulsant effects through multiple mechanisms: blocks voltage-gated sodium channels, enhances GABA-A receptor activity, antagonizes AMPA/kainate glutamate receptors, and weakly inhibits carbonic anhydrase (isoenzymes II and IV). This multifaceted action reduces neuronal excitability and seizure propagation.

Class
Antiepileptic
Dosing

Dosing & protocol.

Common range
25-50 mg/day initially, titrated to 200-400 mg/day in divided doses for epilepsy; 50-100 mg/day for migraine prophylaxis (as prescribed by your physician)
Recommended form
Oral tablets or sprinkle capsules

Rapidly absorbed; bioavailability ~80% and not significantly affected by food. Swallow tablets whole; sprinkle capsules can be opened onto soft food.

Depletions

What it depletes.

Nutrients this medication can lower over time, and what to replace.

Calcium

Mild

Topiramate therapy has been associated with changes in bone and mineral metabolism, including lower calcium status markers in some patients.

Replace CalciumMonitor Serum calcium + 25-OH vitamin D + bone density trendOnset Usually over months of chronic therapy
Safety

Full safety detail.

Side effects

  • Cognitive dysfunction (word-finding difficulty, impaired concentration)
  • Paresthesias (tingling in extremities)
  • Weight loss and decreased appetite
  • Kidney stones (calcium phosphate)
  • Metabolic acidosis
  • Fatigue and somnolence
  • Acute myopia and secondary angle-closure glaucoma (rare)

Contraindications

  • Known hypersensitivity to topiramate1,2
  • Concurrent use with alcohol (increased CNS depression and metabolic acidosis risk)2,5
  • Metabolic acidosis with concurrent metformin use
  • Pregnancy (FDA category D; associated with cleft lip/palate)4
Interactions

Interaction records.

ModerateSynergy

Vitamin D3

Topiramate can reduce vitamin D levels and increase kidney stone risk. Vitamin D supplementation helps prevent bone loss but the carbonic anhydrase inhibition may increase calcium stone risk.

Recommendation: Monitor vitamin D levels. Supplement with 1000-2000 IU/day D3. Monitor calcium/renal function given topiramate's carbonic anhydrase inhibition and nephrolithiasis risk.

ModerateSynergy

Potassium

Topiramate can cause renal carbonic anhydrase inhibition, metabolic acidosis, low urinary citrate, and sometimes low potassium, which increases kidney-stone risk. Potassium citrate, a prescription potassium-containing alkali, has clinical evidence for raising urinary citrate in topiramate users with hypocitraturia. Plain over-the-counter potassium tablets are not the same as potassium citrate and should not be used to self-treat topiramate-related acidosis.

Recommendation: Ask your clinician about bicarbonate, potassium, and kidney-stone risk monitoring if you take topiramate long term. Use potassium or potassium citrate only when directed by a clinician, especially if you have kidney disease or take ACE inhibitors, ARBs, NSAIDs, or spironolactone. Seek care for flank pain, blood in urine, severe fatigue, rapid breathing, or persistent vomiting.

ModerateCaution

Vitamin C

Topiramate increases kidney-stone risk by causing alkaline urine and hypocitraturia. High-dose vitamin C can increase urinary oxalate and has been associated with higher kidney-stone risk, particularly in men. Combining topiramate with high-dose vitamin C is most concerning in people with prior stones, low fluid intake, ketogenic diets, or other stone risks.

Recommendation: Avoid high-dose vitamin C while taking topiramate unless your clinician has a specific reason for it. Keep vitamin C near dietary or standard multivitamin amounts, maintain good hydration, and ask about urine or blood monitoring if you have a stone history. Seek care for flank pain, blood in urine, fever, or vomiting.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

5

Reviews & position papers

2
Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Topiramate in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.